Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Medical cannabis as an alternative therapeutics for Parkinsons' disease: Systematic review.
- A. Bougea, Christos Koros, A. Simitsi, C. Chrysovitsanou, Athanasios Leonardos, L. Stefanis
- Complementary therapies in clinical practice
- 31 March 2020
There is insufficient evidence to reform international legislation regarding cannabis use in PD practice and the positive effects described in uncontrolled studies have not been confirmed by the few and small RCTs. Expand
Mirtazapine-associated urinary retention.
Mirtazapine-Associated Urinary Retention
The administration of low-dose mirtazapine resulted in the patient’s urinary retention, whereby the possibility of incomplete voiding cannot be excluded, and this case is reported on. Expand
REM Sleep Behavior Disorder and other sleep abnormalities in p. A53T SNCA mutation carriers.
The paucity of a sleep disorder in the asymptomatic carriers suggests that such carriers have not yet reached the prodromal phase when such sleep disorders manifest. Expand